Senores Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	May '26 May 22, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Capitalization	51,163	34,982	26,278	-	-	-
Market Cap Growth	119.73%	33.12%	-	-	-	-
Enterprise Value	53,297	35,572	28,923	-	-	-
Last Close Price	1110.95	759.60	570.60	-	-	-
PE Ratio	42.10	30.06	44.87	-	-	-
Forward PE	33.67	25.94	-	-	-	-
PS Ratio	8.09	5.15	6.60	-	-	-
PB Ratio	5.30	3.63	3.24	-	-	-
P/TBV Ratio	9.33	6.38	4.65	-	-	-
P/OCF Ratio	82.45	56.38	-	-	-	-
PEG Ratio	1.59	0.57	-	-	-	-
EV/Sales Ratio	8.42	5.23	7.26	-	-	-
EV/EBITDA Ratio	31.66	16.52	32.78	-	-	-
EV/EBIT Ratio	38.88	19.32	39.69	-	-	-
Debt / Equity Ratio	0.36	0.36	0.39	1.11	1.38	0.40
Debt / EBITDA Ratio	1.59	1.59	3.51	6.28	5.56	10.62
Net Debt / Equity Ratio	0.19	0.19	-0.09	1.06	1.37	0.32
Net Debt / EBITDA Ratio	0.85	0.85	-0.80	6.05	5.71	9.15
Net Debt / FCF Ratio	-0.90	-0.90	0.35	-3.16	-1.29	-0.55
Asset Turnover	0.48	0.48	0.43	0.57	0.37	-
Inventory Turnover	3.45	3.45	3.99	5.38	4.19	-
Quick Ratio	1.14	1.14	2.60	0.77	0.74	2.31
Current Ratio	1.92	1.92	3.00	1.01	0.99	2.74
Return on Equity (ROE)	13.79%	13.79%	11.18%	23.59%	20.55%	-
Return on Assets (ROA)	8.13%	8.13%	4.93%	5.24%	7.16%	-
Return on Invested Capital (ROIC)	13.95%	14.92%	9.89%	10.81%	9.46%	2.25%
Return on Capital Employed (ROCE)	15.60%	15.60%	7.40%	8.40%	13.80%	2.50%
Earnings Yield	2.27%	3.33%	2.23%	-	-	-
FCF Yield	-3.96%	-5.79%	-7.74%	-	-	-
Buyback Yield / Dilution	-21.26%	-21.26%	-41.13%	-103.16%	-131.33%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.